CLINICAL COURSE OF CHRONIC EPSTEIN-BARR VIRUS INFECTION IN CHILDREN OF PRESCHOOL AGE
DOI:
https://doi.org/10.11603/1681-2727.2024.1.14288Keywords:
Epstein-Barr virus infection children, child, preschool, lymphadenopathyAbstract
SUMMARY. Сlinical features of chronic Epstein-Barr virus infection (EBVI) in preschool children are described. Cytomegalovirus (CMV) and human herpes virus type 6 (HHV-6) infections were also detected.
The aim is to study the features of chronic EBVI clinical manifestations in the reactivation stage and frequency of coinfection with CMV and HHV-6 in preschool children.
Patients and methods. The main group included 40 children aged 3–6 years, infected with EBV, with recurrent respiratory infections, recurrent tonsillitis, with one or more manifestations: lymphadenopathy, fever, nasal breathing difficulty, hypertrophy of the palatine tonsils. The control group included 20 EBV-infected healthy children aged 3-6 years. Antibodies antiVCA IgM, antiEBNA IgG, anti CMV IgM and IgG were detected by ELISA. DNA of EBV, CMV and HHV-6 was detected by PCR in blood and oropharyngeal smear.
Results. Viral replication in the blood was detected in 25 % of cases. In such patients fever, enlargement of the posterior and anterior cervical lymph nodes up to 2–2.5 cm, hypertrophy of the palatine tonsils, hypertrophy of the nasopharyngeal tonsil, hepatomegaly, and post-viral fatigue syndrome were more often detected. Severe lymphadenopathy, adenoid hypertrophy, and the frequency of acute respiratory infections 8–10 per year correlate with virus replication in the blood. In children of the main group, EBV DNA was detected in oropharyngeal smear in 67.5 % of cases, CMV DNA in 15 %, and HHV-6 DNA – in 37.5 %.
Conclusions. In children with chronic EBVI, viraemia was detected in 25 % of cases, and EBV on the tonsils – in 67.5 %. In children with viremia fever, cervical lymphadenopathy, 2–3 grade hypertrophy of the palatine tonsils and 2–3 grade adenoids were detected, frequency of acute respiratory infections was 8–10 times per year, tonsillitis – 4–6 times per year. In children without viremia, lymphadenopathy and tonsillar hypertrophy was less expressed, the incidence of respiratory infections and tonsillitis is lower. Frequency of EBV associated with CMV is 90 %, and with HHV-6 – 95.9 %.
References
Kerr, J. R. (2019). Epstein-Barr virus (EBV) reactivation and therapeutic inhibitors. J Clin Pathol, 72(10), 651-658.
Fugl, A., & Andersen, C. L. (2019). Epstein-Barr virus and its association with disease-a review of relevance to general practice. BMC family practice, 20, 1-8.
Leong, M. M. L., & Lung, M. L. (2021). The impact of Epstein-Barr virus infection on epigenetic regulation of host cell gene expression in epithelial and lymphocytic malignancies. Frontiers in Oncology, 11, 629780.
Coghill, A. E., & Hildesheim, A. (2014). Epstein-Barr virus antibodies and the risk of associated malignancies: review of the literature. American journal of epidemiology, 180(7), 687-695.
van der Weele, P., van Logchem, E., Wolffs, P., van den Broek, I., Feltkamp, M., de Melker, H., ... & King, A. J. (2016). Correlation between viral load, multiplicity of infection, and persistence of HPV16 and HPV18 infection in a Dutch cohort of young women. Journal of Clinical Virology, 83, 6-11.
Balfour, H. H., Jr., Dunmire, S. K., and Hogquist, K. A. (2015). Infectious mononucleosis. Clin Transl Immunology, 4(2), e33.
Houen, G., Trier, N. H., & Frederiksen, J. L. (2020). Epstein-Barr virus and multiple sclerosis. Frontiers in immunology, 11, 587078.
Dasari, V., Bhatt, K. H., Smith, C., & Khanna, R. (2017). Designing an effective vaccine to prevent Epstein-Barr virus-associated diseases: challenges and opportunities. Expert Review of Vaccines, 16(4), 377-390.
Jansen, M. A., Van Den Heuvel, D., Bouthoorn, S. H., Jaddoe, V. W., Hooijkaas, H., Raat, H., ... & Moll, H. A. (2016). Determinants of ethnic differences in cytomegalovirus, Epstein-Barr virus, and herpes simplex virus type 1 seroprevalence in childhood. The Journal of pediatrics, 170, 126-134.
Gares, V., Panico, L., Castagne, R., Delpierre, C., & Kelly-Irving, M. (2017). The role of the early social environment on Epstein Barr virus infection: a prospective observational design using the Millennium Cohort Study. Epidemiology & Infection, 145(16), 3405-3412.
Rostgaard, K., Balfour Jr, H. H., Jarrett, R., Erikstrup, C., Pedersen, O., Ullum, H., ... & Hjalgrim, H. (2019). Primary Epstein-Barr virus infection with and without infectious mononucleosis. PloS one, 14(12), e0226436.
Fafi-Kremer, S., Morand, P., Brion, J. P., Pavese, P., Baccard, M., Germi, R., ... & Seigneurin, J. M. (2005). Long-term shedding of infectious Epstein-Barr virus after infectious mononucleosis. The Journal of infectious diseases, 191(6), 985-989.
Odumade, O. A., Hogquist, K. A., & Balfour Jr, H. H. (2011). Progress and problems in understanding and managing primary Epstein-Barr virus infections. Clinical microbiology reviews, 24(1), 193-209.
Pagano, J. S., Whitehurst, C. B., & Andrei, G. (2018). Antiviral drugs for EBV. Cancers, 10(6), 197.
Carvalho-Queiroz, C., Johansson, M. A., Persson, J. O., Jörtsö, E., Kjerstadius, T., Nilsson, C., ... & Sverremark-Ekström, E. (2016). Associations between EBV and CMV seropositivity, early exposures, and gut microbiota in a prospective birth cohort: a 10-year follow-up. Frontiers in Pediatrics, 4, 93.
Duerkop, B. A., & Hooper, L. V. (2013). Resident viruses and their interactions with the immune system. Nature immunology, 14(7), 654-659.
Pinninti, S., Hough-Telford, C., Pati, S., & Boppana, S. (2016). Cytomegalovirus and Epstein-Barr virus infections. Pediatrics in review, 37(6), 223-234.
Lachmann, R., Loenenbach, A., Waterboer, T., Brenner, N., Pawlita, M., Michel, A., ... & Wiese-Posselt, M. (2018). Cytomegalovirus (CMV) seroprevalence in the adult population of Germany. PloS one, 13(7), e0200267.
Zerr, D. M., Meier, A. S., Selke, S. S., Frenkel, L. M., Huang, M. L., Wald, A., ... & Corey, L. (2005). A population-based study of primary human herpesvirus 6 infection. New England Journal of Medicine, 352(8), 768-776.
Vyhovska, O. V. (2016). Herpesvirus infections in children: classification, clinical forms, manifestations, social and medical aspects. Dytyachyy likar – Pediatrician, 49(4), 41-51 [in Ukrainian].
Besh, L. V. (2015). Evaluation of the effectiveness of interferon drugs in the treatment of acute respiratory viral infections in children who are often ill. Zdorovya dytyny – Child’s health, 61(2), 32-36 [in Ukrainian].
Chiappini, E., Santamaria, F., Marseglia, G. L., Marchisio, P., Galli, L., Cutrera, R., ... & Villani, A. (2021). Prevention of recurrent respiratory infections: inter-society consensus. Italian journal of pediatrics, 47, 1-17.
Eligio, P., Delia, R., & Valeria, G. (2010). EBV chronic infections. Mediterranean journal of hematology and infectious diseases, 2(1).
Yang, Y., & Gao, F. (2020). Clinical characteristics of primary and reactivated Epstein‐Barr virus infection in children. Journal of medical virology, 92(12), 3709-3716.
FadenH, C. (2016). Поширеність безсимптомних респіраторних вірусних інфекцій у мигдалинах і даденоїдах у дітей та їх вплив на обструкцію дихальних шляхів. IntJPediatrOtorhinolaryngol , 90 , 128-132.
Kourieh, A., Gheit, T., Tommasino, M., Dalstein, V., Clifford, G. M., Lacau St Guily, J., ... & SPLIT Study Group. (2019). Prevalence of human herpesviruses infections in nonmalignant tonsils: The SPLIT study. Journal of Medical Virology, 91(4), 687-697.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Наталія Горбаль
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal Infectious Disease (Infektsiini Khvoroby) allows the author(s) to hold the copyright without registration
Users can use, reuse and build upon the material published in the journal but only for non-commercial purposes
This journal is available through Creative Commons (CC) License BY-NC "Attribution-NonCommercial" 4.0
